• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Chantix and Prevnar 13?









What's odd is that Pfizer keeps trying to sell products with no legs left. At least they put it in an existing sales force and not pay PDI to sell it. I like my prevnar rep and hope she can move some chantix
 












question is which bu is going away? Vaccines or Primary care.

PCBU keeps giving away volume (Pristiq to AZ, now Chantix/Premarin oral to share volume with Vac). Since PCBU and Vac areseperate profit centers, it's a loss of volume for PCBU increase for vaccines.

Who wins?
 




Vaccines. Prevnar has time to grow and now more products in the bag. PC has to find lower cost ways to sell old products. It's either Vaccines or P4, either way, we lose.
 








Similar threads

Replies
5
Views
901
Pfizer
anonymous
Replies
9
Views
2K
Pfizer
anonymous
Replies
1
Views
567
Pfizer
anonymous
Replies
0
Views
780
Pfizer
anonymous
Replies
3
Views
1K
Pfizer
anonymous